QIAGEN Q2 Profit Tops Estimates; Sales Up 16%

(RTTNews) - QIAGEN N.V. (QGEN) reported that its second quarter adjusted earnings per share increased to $0.55 ($0.56 CER), from $0.33, last year. On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $0.46, for the quarter. Analysts' estimates typically exclude special items.

Second quarter total net sales rose 16% to $443.3 million from $381.6 million, last year. Growth was 19% at constant exchange rates (CER). Analysts expected revenue of $425.82 million for the quarter.

"The unprecedented demand for products used in coronavirus testing is driving QIAGEN's performance in 2020," said Thierry Bernard, CEO of QIAGEN N.V.

QIAGEN Boards have reaffirmed unanimous recommendation that the company's shareholders accept Thermo Fisher Offer and tender their shares on or before August 10.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More